173 related articles for article (PubMed ID: 8062647)
1. [Molecular genetics and biology in the etiology of cancer].
Alitalo K; Pettersson R
Duodecim; 1993; 109(10):809-13. PubMed ID: 8062647
[No Abstract] [Full Text] [Related]
2. [Molecular genetics methods discovering the mechanisms of neoplasm etiology].
Fioretos T; Aman P
Lakartidningen; 1991 Aug; 88(32-33):2597-602. PubMed ID: 1881216
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of oncogenes and tumor suppressor genes in human malignancy.
Spandidos DA; Liloglou T; Field JK
Stem Cells; 1993 May; 11(3):194-8. PubMed ID: 8318905
[TBL] [Abstract][Full Text] [Related]
4. One decade of comparative molecular carcinogenesis.
Goodrow TL
Prog Clin Biol Res; 1996; 395():57-80. PubMed ID: 8895984
[TBL] [Abstract][Full Text] [Related]
5. Oncogenes and growth factors--an updating.
Ernberg IT
Eur J Surg Suppl; 1991 May; (561):15-20. PubMed ID: 1720043
[No Abstract] [Full Text] [Related]
6. Oncogenes and anti-oncogenes; the molecular basis of tumour behaviour.
Wynford-Thomas D
J Pathol; 1991 Nov; 165(3):187-201. PubMed ID: 1762031
[No Abstract] [Full Text] [Related]
7. Modeling cancer in mice.
Jackson-Grusby L
Oncogene; 2002 Aug; 21(35):5504-14. PubMed ID: 12154411
[TBL] [Abstract][Full Text] [Related]
8. [Oncogene and tumor suppressor gene].
Watanabe N
Rinsho Byori; 2002 Nov; Suppl 123():131-6. PubMed ID: 12652800
[TBL] [Abstract][Full Text] [Related]
9. [Cancer and oncogenesis].
Bloemena E
Ned Tijdschr Tandheelkd; 2008 Apr; 115(4):180-5. PubMed ID: 18512515
[TBL] [Abstract][Full Text] [Related]
10. Immunoprevention of cancer: time to reconsider timing of vaccination against cancer.
Spisek R
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1689-91. PubMed ID: 17181481
[No Abstract] [Full Text] [Related]
11. p63: oncogene or tumor suppressor?
Mills AA
Curr Opin Genet Dev; 2006 Feb; 16(1):38-44. PubMed ID: 16359856
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice as an in vivo model of lymphomagenesis.
Tarantul VZ
Int Rev Cytol; 2004; 236():123-80. PubMed ID: 15261738
[TBL] [Abstract][Full Text] [Related]
13. Dying by default, the biology of apoptosis: a review.
Olasode BJ
East Afr Med J; 1997 Feb; 74(2):108-11. PubMed ID: 9185397
[TBL] [Abstract][Full Text] [Related]
14. Oncogenes and tumor suppressor genes: therapeutic implications.
Stass SA; Mixson J
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2687-95. PubMed ID: 10068275
[TBL] [Abstract][Full Text] [Related]
15. Mammary gland neoplasia: insights from transgenic mouse models.
Siegel PM; Hardy WR; Muller WJ
Bioessays; 2000 Jun; 22(6):554-63. PubMed ID: 10842309
[TBL] [Abstract][Full Text] [Related]
16. Transgenic and gene disruption techniques in the study of neurocarcinogenesis.
Aguzzi A; Brandner S; Isenmann S; Steinbach JP; Sure U
Glia; 1995 Nov; 15(3):348-64. PubMed ID: 8586469
[TBL] [Abstract][Full Text] [Related]
17. Cellular epigenetics and the origin of cancer.
Cuthill S
Bioessays; 1994 Jun; 16(6):393-4. PubMed ID: 8080428
[No Abstract] [Full Text] [Related]
18. Oncogenes, cancer and imaging.
Urbain JL
J Nucl Med; 1999 Mar; 40(3):498-504. PubMed ID: 10086717
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective.
Sakorafas GH; Tsiotou AG; Tsiotos GG
Cancer Treat Rev; 2000 Feb; 26(1):29-52. PubMed ID: 10660490
[TBL] [Abstract][Full Text] [Related]
20. Molecular biology of prostate cancer.
Karayi MK; Markham AF
Prostate Cancer Prostatic Dis; 2004; 7(1):6-20. PubMed ID: 14999233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
